Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13177064 | 0.82 | — | — | |
| L-Fucose SCHEMBL5323407 | 0.79 | TDP1 (0.46) | AKR1B1TDP1PAX8 | |
| Demannose SCHEMBL27565181 | 0.79 | LMNA (0.50) | AKR1B1TDP1PAX8 | |
| SCHEMBL14346962 | 0.79 | TDP1 (0.53) | TDP1TSHR | |
| SCHEMBL13537813 | 0.78 | AKR1B1 (0.42) | AKR1B1TDP1PAX8TSHR | |
| SCHEMBL13384832 | 0.78 | AKR1B1 (0.42) | AKR1B1TDP1PAX8TSHR | |
| Demannose SCHEMBL27549555 | 0.77 | LMNA (0.48) | AKR1B1TDP1PAX8 | |
| Xylose SCHEMBL27994956 | 0.77 | LMNA (0.42) | AKR1B1TDP1PAX8 | |
| Demannose SCHEMBL627176 | 0.77 | LMNA (0.48) | AKR1B1TDP1PAX8TSHR | |
| L-Fucose SCHEMBL9241675 | 0.77 | ALDH1A1 (0.39) | AKR1B1TDP1PAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180118884-A1 | USE OF CO2 FOR THE SYNTHESIS OF CYCLIC GLYCOCARBONATES AND LINEAR POLYGLYCOCARBONATES BY POLYCONDENSATION FROM GLYCANS | UNIV KING ABDULLAH SCI & TECH (SA) | 2018-05-03 | — | — | US | disclosed |
| US-20100317123-A1 | Method and Device for Detection of an Analyte | ORION DIAGNOSTICA OY (FI) | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118884-A1 | USE OF CO2 FOR THE SYNTHESIS OF CYCLIC GLYCOCARBONATES AND LINEAR POLYGLYCOCARBONATES BY POLYCONDENSATION FROM GLYCANS | ALG1, CSGALNACT1, ALG8 | AKR1B1 4228/4885TDP1 4701/4885PAX8 3304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.